Guardian Pharmacy Services, Inc.
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.69% | 9.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.69% | 9.27% | |||
| Cost of Revenue | 7.08% | 10.45% | |||
| Gross Profit | 10.23% | 4.61% | |||
| SG&A Expenses | -72.26% | 261.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.26% | 52.22% | |||
| Operating Income | 120.26% | -938.98% | |||
| Income Before Tax | 115.35% | -1,020.90% | |||
| Income Tax Expenses | 2,388.64% | -- | |||
| Earnings from Continuing Operations | 111.19% | -1,022.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 101.49% | -43.14% | |||
| Net Income | 110.60% | -1,779.94% | |||
| EBIT | 120.26% | -938.98% | |||
| EBITDA | 126.45% | -676.45% | |||
| EPS Basic | 109.65% | -1,718.69% | |||
| Normalized Basic EPS | 117.61% | -3,131.55% | |||
| EPS Diluted | 109.63% | -1,723.15% | |||
| Normalized Diluted EPS | 117.42% | -3,131.55% | |||
| Average Basic Shares Outstanding | 1.47% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.59% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.06% | |||